Form 4 for GILD Gilead Sciences
Accepted 2026-08-21 19:22:17 ET · period of report 2026-08-20 · accession 0001771814-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-21 19:22 | 2026-08-20 | GILD | Bluestone Jeffrey | Dir | M - OptEx | $67.04 | +5,000 | 10.4K | +93% | +$335.2K |
| DMT | 2026-08-21 19:22 | 2026-08-20 | GILD | Bluestone Jeffrey | Dir | S - Sale+OE | $145.02 | -5,000 | 10.1K | -33% | -$725.1K |
| DMT | 2026-08-21 19:22 | 2026-08-20 | GILD | Bluestone Jeffrey | Dir | M - OptEx | $0.00 | -5,000 | 11.4K | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-20 | M | A | 1,165 | $67.45 | 11,231 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. |
| 2 | Common | Common Stock | 2026-08-20 | S | D | 1,165 | $143.75 | 10,066 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. (F2) Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| 3 | Common | Common Stock | 2026-08-20 | M | A | 1,816 | $67.45 | 11,882 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. |
| 4 | Common | Common Stock | 2026-08-20 | S | D | 1,816 | $144.92 | 10,066 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. (F3) Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| 5 | Common | Common Stock | 2026-08-20 | M | A | 1,658 | $67.45 | 11,724 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. |
| 6 | Common | Common Stock | 2026-08-20 | S | D | 1,658 | $145.73 | 10,066 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. (F4) Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| 7 | Common | Common Stock | 2026-08-20 | M | A | 26 | $67.45 | 10,092 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. |
| 8 | Common | Common Stock | 2026-08-20 | S | D | 26 | $146.36 | 10,066 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. |
| 9 | Common | Common Stock | 2026-08-20 | M | A | 335 | $61.35 | 10,401 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. |
| 10 | Common | Common Stock | 2026-08-20 | S | D | 335 | $146.26 | 10,066 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. |
| 11 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-08-20 | M | D | 4,665 | $0.00 | 0 | D | $67.45 · — to 2031-05-12 | 4,665 Common Stock | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. (F5) 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. |
| 12 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-08-20 | M | D | 335 | $0.00 | 11,395 | D | $61.35 · — to 2032-05-05 | 335 Common Stock | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. (F6) 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. |